Multiple Myeloma with Hyperammonemia Treated with Novel Agents: A Case Series of Three Patients

Multiple myeloma (MM) is a cancer characterized by the expansion of plasma cells in the bone marrow. Survival times of patients with MM have increased due to the development of novel therapeutic agents. We herein highlight three MM cases that had a poor prognosis despite treatment with novel therape...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakamura, Hajime, Takada, Kohichi, Murase, Kazuyuki, Ikeda, Hiroshi, Iyama, Satoshi, Manabe, Tatsuo, Kobune, Masayoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10037000/
https://www.ncbi.nlm.nih.gov/pubmed/35871579
http://dx.doi.org/10.2169/internalmedicine.0010-22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10037000/
https://www.ncbi.nlm.nih.gov/pubmed/35871579
http://dx.doi.org/10.2169/internalmedicine.0010-22

Ejemplares similares